Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

OBJECTIVE: Incident type 2 diabetes is common among patients with recent acute coronary syndrome and is associated with an adverse prognosis. Some data suggest that cholesteryl ester transfer protein (CETP) inhibitors reduce incident type 2 diabetes. We compared the effect of treatment with the CETP...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Care
Main Authors: Schwartz, Gregory G., Leiter, Lawrence A., Ballantyne, Christie M., Barter, Philip J., Black, Donald M., Kallend, David, Laghrissi-Thode, Fouzia, Leitersdorf, Eran, McMurray, John J.V., Nicholls, Stephen J., Olsson, Anders G., Preiss, David, Shah, Prediman K., Tardif, Jean-Claude, Kittelson, John
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2020
Assuntos:
Emerging Therapies: Drugs and Regimens
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171952/
https://ncbi.nlm.nih.gov/pubmed/32144166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-2204
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares